[Inhibitory analysis of DNA polymerases from human viruses using modified substrates]

Area of Science:

• Molecular Biology
• Virology
• Biochemistry

Context:

• Viral DNA polymerases are essential for viral replication and represent key targets for antiviral therapies.
• Understanding the mechanisms of DNA polymerase inhibition is crucial for developing effective antiviral drugs.
• Modified nucleoside/nucleotide analogs are widely explored for their potential to inhibit viral DNA synthesis.

Purpose:

• To systematically analyze the DNA polymerase enzymes from human herpes simplex virus type 1 (HSV-1), cytomegalovirus (CMV), and human adenovirus type 2 (HAdV2).
• To identify and characterize modified substrates that can inhibit the DNA synthesis catalyzed by these viral DNA polymerases.
• To investigate the molecular mechanisms underlying the inhibition of viral DNA synthesis.

Summary:

• A comprehensive analysis of HSV-1, CMV, and HAdV2 DNA polymerases using a diverse range of modified substrates was performed.
• The study identified compounds that inhibit DNA synthesis catalyzed by all three viral enzymes, as well as human placental DNA polymerase alpha.
• Specific inhibitors were discovered that selectively target certain viral DNA polymerases, acting either by terminating DNA elongation or by non-incorporative inhibition.

Impact:

• Discovery of novel inhibitory compounds provides a foundation for developing new antiviral agents against herpesviruses and adenoviruses.
• Elucidation of distinct inhibition mechanisms (chain termination vs. non-incorporative) offers insights into drug design strategies.
• Identification of inhibitors targeting human DNA polymerase alpha suggests potential applications in cancer chemotherapy.